These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 37287468)

  • 1. Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis.
    Dos Santos DA; Souza HFS; Silber AM; de Souza TACB; Ávila AR
    Front Cell Infect Microbiol; 2023; 13():1175409. PubMed ID: 37287468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinases of Toxoplasma gondii: functions and drug targets.
    Wei F; Wang W; Liu Q
    Parasitol Res; 2013 Jun; 112(6):2121-9. PubMed ID: 23681193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triclabendazole and clofazimine reduce replication and spermine uptake in vitro in Toxoplasma gondii.
    Corvi MM; Rossi F; Ganuza A; Alonso AM; Alberca LN; Dietrich RC; Gavernet L; Talevi A
    Parasitol Res; 2023 Dec; 123(1):69. PubMed ID: 38135783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
    Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
    Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for small molecule inhibitors of Toxoplasma gondii.
    Kortagere S
    Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine.
    Jafarpour Azami S; Mohammad Rahimi H; Mirjalali H; Zali MR
    World J Microbiol Biotechnol; 2021 Feb; 37(3):48. PubMed ID: 33566198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antibacterials for the treatment of toxoplasmosis; a patent review.
    Rodriguez JB; Szajnman SH
    Expert Opin Ther Pat; 2012 Mar; 22(3):311-33. PubMed ID: 22404108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents
    Débare H; Moiré N; Baron F; Lantier L; Héraut B; Van Langendonck N; Denevault-Sabourin C; Dimier-Poisson I; Debierre-Grockiego F
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.
    Leesombun A; Iijima M; Umeda K; Kondoh D; Pagmadulam B; Abdou AM; Suzuki Y; Ohba SI; Isshiki K; Kimura T; Kubota Y; Sawa R; Nihei CI; Nishikawa Y
    J Infect Dis; 2020 Feb; 221(5):766-774. PubMed ID: 31573038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasion and egress by the obligate intracellular parasite Toxoplasma gondii: potential targets for the development of new antiparasitic drugs.
    Lavine MD; Arrizabalaga G
    Curr Pharm Des; 2007; 13(6):641-51. PubMed ID: 17346179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
    Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog.
    Kato K; Sugi T; Takemae H; Takano R; Gong H; Ishiwa A; Horimoto T; Akashi H
    Parasit Vectors; 2016 Jul; 9(1):405. PubMed ID: 27444499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid biology of Apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii.
    Sonda S; Hehl AB
    Trends Parasitol; 2006 Jan; 22(1):41-7. PubMed ID: 16300997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid metabolism: the potential targets for toxoplasmosis treatment.
    He TY; Li YT; Liu ZD; Cheng H; Bao YF; Zhang JL
    Parasit Vectors; 2024 Mar; 17(1):111. PubMed ID: 38448975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human toxoplasmosis-Searching for novel chemotherapeutics.
    Antczak M; Dzitko K; Długońska H
    Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
    Deng Y; Wu T; Zhai SQ; Li CH
    Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutics for
    Wu RZ; Zhou HY; Song JF; Xia QH; Hu W; Mou XD; Li X
    J Med Chem; 2021 Dec; 64(24):17627-17655. PubMed ID: 34894691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TgTKL4 Is a Novel Kinase That Plays an Important Role in
    Montano H; Anandkrishnan R; Carruthers VB; Gaji RY
    mSphere; 2023 Apr; 8(2):e0064922. PubMed ID: 36786615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.
    Vidadala RS; Rivas KL; Ojo KK; Hulverson MA; Zambriski JA; Bruzual I; Schultz TL; Huang W; Zhang Z; Scheele S; DeRocher AE; Choi R; Barrett LK; Siddaramaiah LK; Hol WG; Fan E; Merritt EA; Parsons M; Freiberg G; Marsh K; Kempf DJ; Carruthers VB; Isoherranen N; Doggett JS; Van Voorhis WC; Maly DJ
    J Med Chem; 2016 Jul; 59(13):6531-46. PubMed ID: 27309760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.